WallStSmart
FLGT

Fulgent Genetics Inc

NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH

$15.19
+2.64% today

Updated 2026-04-30

Market cap
$470.46M
P/E ratio
P/S ratio
1.46x
EPS (TTM)
$-1.97
Dividend yield
52W range
$13 – $31
Volume
0.7M

Fulgent Genetics Inc (FLGT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$1.28M$9.58M$18.28M$18.73M$21.36M$32.53M$421.71M$992.58M$618.97M$289.21M$283.47M$322.67M
Revenue growth (YoY)+649.3%+90.9%+2.5%+14.0%+52.3%+1196.5%+135.4%-37.6%-53.3%-2.0%+13.8%
Cost of revenue$936000.00$5.07M$6.72M$8.55M$10.69M$14.11M$89.81M$215.53M$252.07M$184.76M$176.25M$191.80M
Gross profit$342000.00$4.51M$11.55M$10.18M$10.66M$18.42M$331.90M$777.05M$366.90M$104.46M$107.22M$130.88M
Gross margin26.8%47.1%63.2%54.3%49.9%56.6%78.7%78.3%59.3%36.1%37.8%40.6%
R&D$521000.00$4.43M$3.56M$4.22M$5.53M$6.54M$11.58M$24.22M$28.91M$41.44M$48.82M$53.91M
SG&A$230000.00$2.42M$4.61M$5.13M$5.54M$6.41M$15.21M$50.73M$111.07M$89.00M$88.11M$116.66M
Operating income$-990000.00$-5.01M$919000.00$-3.40M$-5.06M$-428000.00$290.16M$104.34M$178.53M$-195.53M$-73.92M$-91.10M
Operating margin-77.5%-52.3%5.0%-18.2%-23.7%-1.3%68.8%10.5%28.8%-67.6%-26.1%-28.2%
EBITDA$-794000.00$-4.44M$2.09M$-1.67M$-2.89M$1.68M$293.12M$106.05M$217.70M$-147.45M$-48.99M$-45.83M
EBITDA margin-62.1%-46.3%11.4%-8.9%-13.6%5.2%69.5%10.7%35.2%-51.0%-17.3%-14.2%
EBIT$-990000.00$-5.01M$919000.00$-3.40M$-5.06M$-428000.00$290.16M$104.34M$185.04M$-173.60M$-73.92M$-69.95M
Interest expense$0.00$0.00$5.39M$0.00$0.00$2.17M$354000.00$6.21M$1.01M$488000.00$170000.00$75000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.28M$-8.31M$-5.39M$-2.66M$-4.49M$366000.00$214.31M$104.34M$143.40M$-167.82M$-42.71M$-60.51M
Net income growth (YoY)-94.1%+35.2%+50.6%-68.7%+108.2%+58454.6%-51.3%+37.4%-217.0%+74.6%-41.7%
Profit margin-335.1%-86.8%-29.5%-14.2%-21.0%1.1%50.8%10.5%23.2%-58.0%-15.1%-18.8%